论文部分内容阅读
联合应用东菱精纯克栓酶（BTX）和尼莫通（NMT）治疗40例早期脑梗塞，与对照组42例比较，两组显效率有极显著的差异（P＜0．001）。治疗组使用BTX和NMT的早与迟，其疗效有极显著的差异（P＜0．01），且临床症状和体征开始改善的时间也有极显著的差异（P＜0．01）。这提示，联合应用BTX和NMT治疗早期脑梗塞疗效显著，且使用时间越早，疗效越佳。
Forty cases of early cerebral infarction were treated with combination of DFX and NMT. Compared with the control group, 42 cases showed significant difference (P <0.001). There was a significant difference (P <0.01) between the two groups in the early and late treatment of BTX and NMT. There was also a significant difference (P <0.01) between the onset of clinical symptoms and signs. This suggests that the combination of BTX and NMT treatment of early cerebral infarction significant effect, and the use of the earlier, the better the effect.